Skip to main content
Lisa Zaba, MD, Dermatology, Palo Alto, CA, Stanford Health Care

LisaZabaMDPhD

Dermatology Palo Alto, CA

Clinical Associate Professor

Dr. Zaba is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Zaba's full profile

Already have an account?

Summary

  • Lisa Zaba M.D. Ph.D., is Clinical Associate Professor of Dermatology and Director of the South Bay Cutaneous Oncology Program. She has a special interest in managing skin complications in cancer patients while they receive treatment including skin rashes, graft versus host disease, and skin cancer. She also has a special interest in rheumatologic diseases and autoimmunity that can be caused by some forms of immune based chemotherapeutics. At the South Bay Cancer Center (CCSB) she leads the multi-disciplinary melanoma clinic. Dr. Zaba completed medical school at Cornell University, PhD in immunology at Rockefeller University, Residency and Post-Doc at Stanford University in 2013.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 2010 - 2013
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2009

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2026
  • American Board of Dermatology Dermatology

Publications & Presentations

PubMed

Press Mentions

  • Do You Need a COVID-19 Vaccine Booster if You Have Psoriasis?
    Do You Need a COVID-19 Vaccine Booster if You Have Psoriasis?August 30th, 2021
  • Merkel Cell Carcinoma. Jimmy Buffett Had It. Here’s How to Reduce Your Risk
    Merkel Cell Carcinoma. Jimmy Buffett Had It. Here’s How to Reduce Your RiskSeptember 8th, 2023
  • High Rate of Subsequent Cancers in MCC
    High Rate of Subsequent Cancers in MCCSeptember 20th, 2023
  • Join now to see all

Hospital Affiliations